Herquline A, produced by Penicillium herquei FKI-7215, exhibits anti-influenza virus properties
Authors:
- 2 January 2017
- journal article
- research article
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 81 (1) , 59-62
Abstract
In the course of screening for new anti-influenza virus antibiotics, we isolated herquline A from a culture broth of the fungus, Penicillium herquei FKI-7215. Herquline A inhibited replication of influenza virus A/PR/8/34 strain in a dose-dependent manner without exhibiting cytotoxicity against several human cell lines. It did not inhibit the viral neuraminidase.Keywords
This publication has 10 references indexed in Scilit:
- Akt Inhibitor MK2206 Prevents Influenza pH1N1 Virus Infection In VitroAntimicrobial Agents and Chemotherapy, 2014
- Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral ActivityScience, 2013
- Wickerols A and B: novel anti-influenza virus diterpenes produced by Trichoderma atroviride FKI-3849Tetrahedron, 2012
- Emergence and pandemic potential of swine-origin H1N1 influenza virusNature, 2009
- The war against influenza: discovery and development of sialidase inhibitorsNature Reviews Drug Discovery, 2007
- Oseltamivir Resistance in Influenza A (H5N1) InfectionNew England Journal of Medicine, 2006
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- Herquline B, a New Platelet Aggregation Inhibitor Produced by Penicillium herquei Fg-372.The Journal of Antibiotics, 1996
- Herquline, a new alkaloid produced by Penicillium herquei. Fermentation, isolation and properties.The Journal of Antibiotics, 1979